Paper9502073
Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist.
Ignar DM and 8 others. Clin Exp Metastasis, 1998. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist. Papers, record 9502073. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9502073
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunoglobulin G | Major topic |
| Neoplasm Metastasis | Major topic |
| Neoplasm Proteins | Major topic |
| Receptors, Cell Surface | Major topic |
| Recombinant Fusion Proteins | Major topic |
| Animals | |
| Disease Progression | |
| Humans | |
| Mice | |
| Mice, Nude | |
| Mice, SCID | |
| Neoplasm Transplantation | |
| Receptors, Urokinase Plasminogen Activator | |
| Tumor Cells, Cultured |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8362987 | Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. | Am J Pathol | 1993 | https://conductscience.org/library/papers/8362987 | PubMed |
| 2 | 2536017 | Characterization of the cellular binding site for the urokinase-type plasminogen activator. | J Biol Chem | 1989 | https://conductscience.org/library/papers/2536017 | PubMed |
| 3 | 7987854 | Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus. | Cancer Res | 1994 | https://conductscience.org/library/papers/7987854 | PubMed |
| 4 | 1617632 | Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. | Cancer Res | 1992 | https://conductscience.org/library/papers/1617632 | PubMed |
| 5 | 7730348 | Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7730348 | PubMed |
| 6 | 6257680 | Phase separation of integral membrane proteins in Triton X-114 solution. | J Biol Chem | 1981 | https://conductscience.org/library/papers/6257680 | PubMed |
| 7 | 8522347 | The production and characterization of murine monoclonal antibodies to human Gadd45 raised against a recombinant protein. | Hybridoma | 1995 | https://conductscience.org/library/papers/8522347 | PubMed |
| 8 | 113458 | A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. | J Immunol | 1979 | https://conductscience.org/library/papers/113458 | PubMed |
| 9 | 1829461 | Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. | J Biol Chem | 1991 | https://conductscience.org/library/papers/1829461 | PubMed |
| 10 | 8625323 | Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. | Cancer Res | 1996 | https://conductscience.org/library/papers/8625323 | PubMed |
| 11 | 7525077 | Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. | Cell | 1994 | https://conductscience.org/library/papers/7525077 | PubMed |
| 12 | 7988721 | Blockage of the urokinase receptor on the cell surface: construction and characterization of a hybrid protein consisting of the N-terminal fragment of human urokinase and human albumin. | FEBS Lett | 1994 | https://conductscience.org/library/papers/7988721 | PubMed |
| 13 | 7749147 | Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies. | Breast Cancer Res Treat | 1995 | https://conductscience.org/library/papers/7749147 | PubMed |
| 14 | 3193516 | Urokinase-type plasminogen activator as a marker for the formation of distant metastases in prostatic carcinomas. | J Urol | 1988 | https://conductscience.org/library/papers/3193516 | PubMed |
| 15 | 3884145 | Localization of plasminogen activators in human colon cancer by immunoperoxidase staining. | Cancer Res | 1985 | https://conductscience.org/library/papers/3884145 | PubMed |
| 16 | 7523424 | Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells. | J Cell Physiol | 1994 | https://conductscience.org/library/papers/7523424 | PubMed |
| 17 | 8605725 | Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis. | Clin Exp Metastasis | 1996 | https://conductscience.org/library/papers/8605725 | PubMed |
| 18 | 8385942 | Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. | Bioessays | 1993 | https://conductscience.org/library/papers/8385942 | PubMed |
| 19 | 8227186 | Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers. | J Cell Biochem | 1993 | https://conductscience.org/library/papers/8227186 | PubMed |
| 20 | 1988089 | Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse. | Cancer Res | 1991 | https://conductscience.org/library/papers/1988089 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33488965 | Design and Synthesis of Fragment Derivatives with a Unique Inhibition Mechanism of the uPAR·uPA Interaction. | ACS Med Chem Lett | 2021 | https://conductscience.org/library/papers/33488965 | PubMed |
| 27385000 | uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy. | Oncotarget | 2016 | https://conductscience.org/library/papers/27385000 | PubMed |
| 26040548 | Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR. | Clin Exp Metastasis | 2015 | https://conductscience.org/library/papers/26040548 | PubMed |
| 23411397 | Small-molecule inhibition of the uPAR·uPA interaction: synthesis, biochemical, cellular, in vivo pharmacokinetics and efficacy studies in breast cancer metastasis. | Bioorg Med Chem | 2013 | https://conductscience.org/library/papers/23411397 | PubMed |
| 21149615 | Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21149615 | PubMed |
| 19208341 | Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. | Gastroenterology | 2009 | https://conductscience.org/library/papers/19208341 | PubMed |
| 16524486 | The fibrinolytic system facilitates tumor cell migration across the blood-brain barrier in experimental melanoma brain metastasis. | BMC Cancer | 2006 | https://conductscience.org/library/papers/16524486 | PubMed |
| 16170032 | Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. | Mol Cancer Ther | 2005 | https://conductscience.org/library/papers/16170032 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PLAU | 5328 | PubTator's text mining | https://conductscience.org/library/genes/5328 | NCBI Gene |
| PLAUR | 5329 | PubTator's text mining | https://conductscience.org/library/genes/5329 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9502073
GET https://conductscience.org/api/papers/v1/9502073/references?page=2